Novartis AG (FRA:NOTA)

Market Cap	196.24B
Revenue (ttm)	46.99B
Net Income (ttm)	11.63B
Shares Out	n/a
EPS (ttm)	5.83
PE Ratio	16.88
Forward PE	13.59
Dividend	3.10 (3.04%)
Ex-Dividend Date	Mar 12, 2025

Volume	n/a
Average Volume	50
Open	98.60
Previous Close	100.00
Day's Range	98.60 - 102.00
52-Week Range	88.20 - 108.50
Beta	n/a
RSI	49.98
Earnings Date	Jul 17, 2025

About R1 RCM

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Re...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NOTA

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.